The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their “illegal” sales of ...

Today was supposed to mark the beginning of the end for cheaper, knockoff versions of hot weight-loss drugs. The Food and Drug Administration wants bulk production of the copycats to stop—starting ...

How fast can Hims & Hers grow without selling GLP-1 drugs? Maybe a lot faster than you think.

Americans age 65 and older who are insured by Medicare logged about 60 million telehealth visits annually between 2021 and 2023 – about 31 million for mental health and 29 million for other health ...

Hims & Hers and Amwell are taking different paths in telehealth, but which stock offers the stronger opportunity today? Let's ...

Doximity DOCS ended the fiscal 2025 with robust growth in its top line. The performance is also likely to continue in fiscal 2026 as demand for telehealth and related services continues to rise. Total ...